Stockscreener 앱 받기
33.70
0.39%
0.13
시간 외 거래:
33.67
-0.03
-0.09%
전일 마감가:
$33.57
열려 있는:
$33.57
하루 거래량:
350.55K
Relative Volume:
0.45
시가총액:
$1.47B
수익:
$384.10M
순이익/손실:
$-9.07M
주가수익비율:
-240.71
EPS:
-0.14
순현금흐름:
$11.10M
1주 성능:
+1.48%
1개월 성능:
+27.99%
6개월 성능:
+71.68%
1년 성능:
+24.54%
1일 변동 폭
$33.36
$34.16
1주일 범위
$32.89
$34.24
52주 변동 폭
$17.82
$34.55
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
명칭
Kiniksa Pharmaceuticals International Plc
전화
(781) 431-9100
주소
23 OLD BOND STREET, FLOOR 3, LONDON
KNSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
33.70 | 2.49B | 384.10M | -9.07M | 11.10M | -0.14 |
|
ZTS
Zoetis Inc
|
155.37 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.86 | 46.99B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.71 | 43.17B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.05 | 20.82B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
305.35 | 13.98B | 2.99B | 1.21B | 1.13B | 25.06 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2024-09-13 | 개시 | Jefferies | Buy |
| 2024-05-03 | 개시 | Wells Fargo | Overweight |
| 2020-06-29 | 재확인 | BofA Securities | Buy |
| 2020-04-01 | 개시 | BofA/Merrill | Buy |
| 2019-03-11 | 개시 | Barclays | Overweight |
| 2018-12-12 | 재확인 | Wedbush | Outperform |
| 2018-06-19 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Kiniksa Pharmaceuticals International Plc 주식(KNSA)의 최신 뉴스
Russell Investments Group Ltd. Has $1.88 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Is Kiniksa Pharmaceuticals Ltd. a candidate for recovery playSell Signal & Technical Analysis for Trade Confirmation - Newser
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Fox Run Management L.L.C. Acquires Shares of 11,352 Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Nuveen LLC Acquires Shares of 765,054 Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Vanguard Group Inc. Acquires 151,604 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Vanguard Group Inc. Has $74.61 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Algert Global LLC Acquires 94,653 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighStill a Buy? - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
1,473 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Acquired by US Bancorp DE - Defense World
Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to Trade - MSN
Deutsche Bank AG Has $8.76 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Director Sells $1,600,786.80 in Stock - MarketBeat
Thomas Malley Sells 78,233 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Thomas Malley Sells 50,129 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat
Analysts Predict $37 for First Trust Active Factor Small Cap ETF - AInvest
Is Kiniksa Pharmaceuticals Ltd. stock entering bullish territoryWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser
Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why - NewsBreak: Local News & Alerts
Published on: 2025-08-17 04:40:11 - Newser
Connor Clark & Lunn Investment Management Ltd. Buys 92,797 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Zacks.com featured highlights include Modine Manufacturing, Tutor Perini, Kiniksa Pharmaceuticals International and Euroseas - Barchart.com
Insider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Insider Sells 29,325 Shares of Stock - MarketBeat
Eben Tessari Sells 138,614 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat
Michael R. Megna Sells 17,000 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) CFO Sells $621,259.21 in Stock - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month HighShould You Buy? - MarketBeat
BIT Capital GmbH Takes $264,000 Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Kiniksa Pharmaceuticals International Plc (KNSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
1.25%
자본화:
|
볼륨(24시간):